News summary

Insilico Medicine opens AI longevity discovery toolkit

Source: Longevity Technology • Published: 18 Sept 2026, 07:41

Summarized by Masters of Longevity from Longevity Technology.

Insilico’s Cell paper presents an open AI toolkit for aging-research workflows, describing benchmark datasets, compact LLMs, and an agentic target-discovery platform.

Insilico Medicine opens AI longevity discovery toolkit
Key Takeaways
  • Insilico Medicine released three open resources—LongevityBench, Longevity-LLMs, and Longevity Claw—for aging research use.
  • LongevityBench provides standardized benchmarks to evaluate AI reasoning across multiple domains of aging biology.
  • Longevity Claw is an agentic, open-source platform that integrates tools to identify and prioritize therapeutic targets.
Read the full article at Longevity Technology

Continue exploring

Recommended MoL Picks

MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.